by 
The biotechnology reagents and kits market is witnessing significant growth attributed to rising applications of reagents and kits in various molecular and cellular techniques for diagnostics, research, and therapeutics purposes. Biotechnology reagents are consumable materials or biological entities used in molecular biology and clinical molecular diagnostic testing. They are specifically formulated with suitable buffers, stabilizers, and reagents for optimal enzymatic activity and utility in various molecular biology techniques. Key products include DNA and RNA analysis reagents, cell and tissue analysis reagents, and others. They provide consistency, reproducibility, and reliability in molecular techniques.
Global Biotechnology Reagents and Kits Market is estimated to be valued at US$ 718.8 Mn in 2024 and is expected to exhibit a CAGR of 23% over the forecast period from 2023 to 2030.
Growing awareness regarding chronic illnesses and increasing investments in biotechnology are key factors fueling the market growth. Increasing R&D spending on biotherapeutics and biosimilars by biopharmaceutical players worldwide presents significant opportunities for the biotechnology reagents and kits market over the coming years.
Key Takeaways
Key players operating in the Biotechnology Reagents and Kits are Medtronic Plc, Hill-Rom Holdings, Inc. (Welch Allyn), iRythm Technologies, Inc., AliveCor, Inc., Vivalnk, Inc., Cardiac Insight Inc., VitalConnect, LifeSignals, Inc., Lâ€TMoreal Group, Dexcom, Inc., GENTAG, Inc., Abbott Laboratories, Koninklijke Philips N.V. and other prominent players. Prominent players are investing heavily in research activities for developing innovative products to gain a competitive edge in the market.
Growing demand for biotechnology reagents from diagnostic centers, hospitals, and research institutes is expected to drive market growth during the forecast period. Rising need for early and accurate disease diagnosis and growing awareness are expected to significantly contribute to market expansion.
Increasing focus on precision medicine is encouraging global expansion of the biotechnology reagents and kits market. New product approvals and growing investments by leading players to establish manufacturing and distribution networks across developing regions present remunerative growth avenues.
Market Key Trends
Increasing adoption of personalized medicine is one of the key trends observed in the biotechnology reagents and kits market. Molecular diagnostics using reagents are playing a crucial role in developing customized treatment plans for cancer and other chronic diseases. Growth in genomics and proteomics research and demand for companion diagnostics have further propelled the demand for reagents in personalized medicine applications. Expanding applications of biotechnology reagents in reproductive health and non-invasive prenatal testing are expected to shape the future market trends.
Porter’s Analysis
Threat of new entrants: Low barriers to entry in terms of capital requirement and technology. However, established players have advantages in terms of brand, distribution and resources.
Bargaining power of buyers: Buyers have moderate to high bargaining power due to the availability of substitutes and price sensitivity.
Bargaining power of suppliers: High degree of forward integration as suppliers also operate in the subsequent market stages. High cost of shifting to alternatives for suppliers.
Threat of new substitutes: Moderate threat due to continuous innovation and replacements from adjacent industries like molecular biology.
Competitive rivalry: Intense competition among existing players to gain market share through technological advancements and targeting new application areas.
Geographical Regions
North America accounts for the largest share of the biotechnology reagents and kits market in terms of value owing to favorable government initiatives and availability of research funding. Growing research in life sciences and healthcare sector accentuates the market growth.
Asia Pacific exhibits the fastest growth for the biotechnology reagents and kits market led by rising penetration of molecular diagnostic techniques, increasing healthcare expenditure and expansion of private clinical labs in India and China. Growing biotechnology industry, improving healthcare infrastructure along with healthcare reforms drive the regional market.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
